← Leaderboards
Michael Calter
University Of Rochester
$1,546,436
Attributed
$1,546,436
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $492.5K · FY2006–18$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,546,436 · 4
By mechanism
R15$1,206,936 · 3
R29$339,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Paul S Brookes$10,286,136
- Mesut Muyan$1,352,384
- Tristan Marriner Nicholson$137,582
- Jimmy Zhang$124,433
- Steven Edward Lipshultz$33,670,932
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsCarboxylateDrug Design /Synthesis /ProductionBiological ProductsPolymersAntifungal AgentsAntineoplastic AgentsPharmaceutical PreparationsMolecular StructureInvestigationCinchona AlkaloidsAntiviral AgentsBacteriaBaseNew AgentsDrug UsageBiological SystemsFamilyAdverse EffectsFungusCatalystMalignant NeoplasmsOrganic ChemistryProperty
Grant awards (6)
Synthesis of Biologically Active Molecules Using the Interrupted Feist-Bénary and Related Reactions$492,496
R15 · FY2018 · GM · contact PI
Asymmetric C-C Bond-Forming Reactions Catalyzed by Cinchona Alkaloid Derivatives$472,490
R15 · FY2010 · GM · contact PI
The Catalytic, Asymmetric Interrupted Feist-Benary Reaction$241,950
R15 · FY2006 · GM · contact PI
NEW HIGHLY EFFICIENT ROUTES TO POLYKETIDES$122,238
R29 · FY2002 · AI
NEW HIGHLY EFFICIENT ROUTES TO POLYKETIDES$115,367
R29 · FY2001 · AI
NEW HIGHLY EFFICIENT ROUTES TO POLYKETIDES$101,895
R29 · FY2000 · AI